|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 37.00 USD | -2.17% |
|
-0.19% | +20.13% |
| 10-16 | Nordic stocks in North America - Ericsson rose 2.6 percent | FW |
| 10-15 | Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug | RE |
Chart calendar Genmab A/S
Upcoming events on Genmab A/S
| 2026-11-05 | Earnings release - Q3 2026 | 11:00 |
| 2026-11-05 | Earnings presentation | 12:00 |
Past events on Genmab A/S
| 2026-10-07 | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-08-06 | Earnings release - Q2 2026 | 11:00 |
| 2026-08-06 | Earnings presentation | 12:00 |
| 2026-05-07 | Earnings presentation | 12:00 |
| 2026-05-07 | Earnings release - Q1 2026 | 11:00 |
| 2026-03-19 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-03-19 | Annual General Meeting | 09:00 |
| 2026-02-17 | Earnings release - Annual 2025 | 11:00 |
| 2026-02-17 | Earnings presentation | 12:00 |
| 2025-12-11 | Information meeting | 11:00 |
| 2025-11-06 | Earnings presentation | 12:00 |
| 2025-11-05 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 16 474 16 380 0.58% | 21 526 21 291 1.1% | 23 497 23 722 -0.95% | 29 718 | 35 019 | 43 854 |
|
EBITDA Million DKK | Released Forecast Spread | 5 616 5 721 -1.83% | 7 116 6 922 2.8% | 7 175 9 059 -20.79% | 8 863 | 12 364 | 17 311 |
|
EBIT Million DKK | Released Forecast Spread | 5 321 5 398 -1.42% | 7 003 6 441 8.72% | 6 727 8 479 -20.66% | 7 892 | 10 352 | 14 879 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 5 637 6 236 -9.6% | 9 164 7 411 23.66% | 7 605 9 329 -18.48% | 6 225 | 9 240 | 13 991 |
|
Net income Million DKK | Released Forecast Spread | 4 352 4 989 -12.77% | 7 844 5 530 41.86% | 6 083 7 428 -18.11% | 5 020 | 7 289 | 11 412 |
|
EPS DKK | Released Forecast Spread | 66,0 76,1 -13.23% | 121 85,3 42.26% | 97,1 118 -17.67% | 81,4 | 115 | 173 |
| Announcement Date | 14/02/24 | 12/02/25 | 17/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 6 441 6 396 0.7% | 4 731 5 019 -5.73% | 5 934 5 812 2.11% | 6 613 6 373 3.77% | 6 683 6 693 -0.15% | 5 691 5 673 0.33% | 7 493 7 232 3.6% | 13 305 13 446 -1.05% | 8 006 | 8 411 | 7 173 | 9 241 | 10 082 | 10 479 |
|
EBITDA Million DKK | Released Forecast Spread | 2 275 1 969 15.56% | 1 350 986 36.95% | 2 412 2 207 9.32% | 3 087 2 871 7.51% | 499 2 370 -78.95% | 2 601 3 709 -29.87% | 3 957 4 150 -4.66% | 3 758 | 3 274 | |||||
|
EBIT Million DKK | Released Forecast Spread | 2 191 1 945 12.67% | 1 244 1 069 16.32% | 2 310 2 074 11.36% | 2 970 2 445 21.46% | 366 2 259 -83.79% | 1 143 833 37.27% | 2 433 2 250 8.14% | 3 600 3 620 -0.55% | 2 296 | 2 102 | 1 453 | 3 289 | 3 897 | 4 062 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 3 602 1 942 85.46% | 1 615 1 214 32.96% | 2 714 2 174 24.81% | 3 119 2 491 25.22% | 347 2 220 -84.35% | 470 449 4.7% | 1 914 1 852 3.35% | 2 394 2 481 -3.52% | 1 828 | 1 824 | 943 | 2 787 | 3 412 | 3 594 |
|
Net income Million DKK | Released Forecast Spread | 3 845 1 576 143.95% | 1 290 1 068 20.84% | 2 156 1 657 30.06% | 2 595 1 927 34.67% | 196 1 638 -88.04% | 337 374 -9.97% | 1 966 1 425 37.95% | 2 309 1 781 29.7% | 1 401 | 1 217 | 732 | 2 164 | 2 649 | 2 791 |
|
EPS DKK | Released Forecast Spread | 59,6 24,3 145.14% | 20,2 16,0 26.14% | 34,8 24,5 42.1% | 41,8 30,3 37.77% | 2,97 28,5 -89.59% | 5,27 5,68 -7.11% | 31,9 22,8 39.7% | 37,2 28,8 29.05% | 23,9 | 21,0 | 11,9 | 35,2 | 43,1 | 45,4 |
| Announcement Date | 12/02/25 | 08/05/25 | 07/08/25 | 06/11/25 | 17/02/26 | 07/05/26 | 06/08/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-21 |  | Information meeting | 09:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 08:30 |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for Genmab A/S
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-06 | | Information meeting | 10:00 |
| 2026-10-05 | | Information meeting | 08:00 |
| 2026-10-01 | | Présentation aux Actionnaires / Analystes | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Calendar Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
